Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT
Mersana Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -74.04M | -74.01M | -69.19M | -74.62M | -104.77M | -134.81M | -171.67M | -197.05M | -215.21M | -213.12M | -204.21M | -208.27M | -193.93M | -182.63M | -170.06M | -149.92M | -126.94M | -105.81M |
Depreciation & Amortization | -1.93M | -1.81M | -1.71M | -1.66M | 1.7M | 1.62M | 1.52M | 1.35M | 1.14M | 1.04M | 927K | 856K | 855K | 834K | 855K | 904K | 948K | 988K |
Stock-Based Compensation | 12.14M | 14.57M | 16.46M | 17.2M | 17.17M | 19.39M | 21.14M | 22.36M | 23.74M | 22.44M | 21.52M | 21.07M | 20.62M | 19.86M | 18.41M | 15.54M | 12.53M | 9.6M |
Other Working Capital | -19.97M | -21.94M | -26.79M | -30.62M | -36.28M | -45.8M | -44.87M | -9.37M | 89.08M | 96.29M | 145.27M | 124.08M | 38.55M | 45.59M | 9.6M | 17.13M | 10.72M | 7.57M |
Other Non-Cash Items | 1.11M | 1.26M | 9.85M | 9.32M | 8.93M | 9.53M | -1.1M | -1.75M | -1.78M | -1.76M | -303K | 1.18M | 1.03M | 879K | 723K | 157K | 151K | 149K |
Deferred Income Tax | n/a | n/a | n/a | 2.83M | 1.78M | n/a | n/a | -2.83M | -1.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20K |
Change in Working Capital | -17.04M | -19.02M | -28.08M | -40.63M | -49.87M | -60.77M | -20.95M | -10.24M | 106.7M | 121.37M | 133.1M | 145.03M | 40.3M | 40.14M | 10.09M | 18.41M | 14.31M | 14.62M |
Operating Cash Flow | -79.76M | -79.01M | -82.34M | -97.24M | -134.74M | -174.72M | -171.07M | -188.15M | -87.47M | -70.41M | -49.36M | -40.53M | -131.23M | -120.92M | -139.99M | -114.91M | -99M | -80.47M |
Capital Expenditures | n/a | n/a | -132K | -518K | -990K | -1.39M | -2.17M | -2.57M | -2.52M | -2.78M | -2.2M | -1.57M | -1.19M | -863K | -648K | -681K | -830K | -522K |
Cash Acquisitions | n/a | n/a | n/a | 101.52M | -2.73M | 2.31M | n/a | -47.52M | 56.73M | 51.69M | 54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -26.53M | -46.02M | -133.43M | -157.9M | -141.09M | -179.64M | -155.92M | -219.09M | -279.44M | -311.21M | -247.52M | -159.88M | -89.81M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 132M | 157M | 145M | 140M | 198.97M | 226.97M | 277.97M | 275.97M | 162M | 109M | 43M | n/a | n/a | n/a | n/a | -37.5M | -34.5M | -19.5M |
Other Investing Acitivies | 395K | n/a | -72.42M | -173.93M | -69.68M | -74.72M | n/a | 47.52M | -72.8M | -157.57M | -159.88M | -105.88M | -89.81M | n/a | n/a | 37.5M | 40.5M | 55.5M |
Investing Cash Flow | 105.86M | 110.98M | 11.44M | -18.41M | 56.89M | 45.94M | 119.88M | 54.31M | -65.96M | -150.99M | -152.72M | -107.44M | -91M | -863K | -648K | -681K | 2.17M | 17.48M |
Debt Repayment | -5.25M | -5.3M | -2.23M | -201K | -243K | -262K | 21.32M | 21.32M | 21.32M | 21.32M | -272K | 18.27M | 18.27M | 18.3M | 18.34M | 62.67M | 62.69M | 62.7M |
Common Stock Repurchased | n/a | n/a | n/a | 1.2M | 1.12M | 1.12M | 1.12M | -81K | n/a | n/a | n/a | n/a | n/a | n/a | -259K | -259K | -259K | -259K |
Dividend Paid | n/a | n/a | n/a | -227K | -227K | -227K | -227K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.11M | 266K | 314K | 472K | 472K | 1.56M | -20.18M | -18.76M | -18.65M | -19.4M | 2.4M | 1.33M | 1.75M | 1.76M | 2.17M | -122.53M | -123.06M | -58.92M |
Financial Cash Flow | -8.13M | -4.87M | 4.09M | 6.05M | 5.93M | 78.95M | 94.67M | 136.04M | 146.82M | 114.17M | 153.02M | 140.35M | 130.18M | 123.57M | 63.65M | 36.52M | 36M | 230.97M |
Net Cash Flow | 17.97M | 27.1M | -66.81M | -107.42M | -69.73M | -47.64M | 45.68M | 2.2M | -6.61M | -107.23M | -49.06M | -7.63M | -92.05M | 1.78M | -76.99M | -79.07M | -60.83M | 167.98M |
Free Cash Flow | -79.76M | -79.01M | -82.47M | -97.75M | -135.73M | -176.11M | -173.24M | -190.72M | -89.99M | -73.19M | -51.56M | -42.1M | -132.42M | -121.78M | -140.64M | -115.59M | -99.83M | -80.99M |